As of May 2025, corporate stock buyback authorizations are on track to eclipse $1.35 trillion this year, with more than $1 ...

Yes, indeed ... the likely to be higher variable dividend payouts ahead, we are reiterating our Buy rating for the GNK stock. Analyst’s Disclosure: I/we have no stock, option or similar ...

Understanding your market is no longer a luxury—it’s a necessity. But when it comes to research, companies often face a fundamental decision: Should they lean on quantitative methods that offer ...

Women's physical activity levels are less variable than men's, according to a new study published in the Journal of Medical ...

P3 Health Partners Inc. ("P3" or the "Company") , a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, ...

What do Sudoku, AI, Rubik’s cubes, clocks and molecules have in common? They can all be reimagined as algebraic equations.

It's nice to find a secured credit card with a $0 annual fee. Even better is one that offers a path to upgrade to a regular card. This one does both — and it gives you rewards, too. Many or all ...

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...

Clin Lipidology. 2012;7(4):363-365. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the ...

It stressed there were no issues with "clinical efficacy or safety, trial design, labelling, or manufacturing" that could suggest a lengthy delay. The EU approval is based on the results of the ...

In Your Application: We will look for evidence of your interpersonal skills, quantitative abilities, and the ways in which you plan to create impact through business in the future. We are looking for ...